Sultan® Super Estonya - Estonca - Adama

sultan® super

adama - suspensioonikontsentraat - kvinmerak + metasakloor - herbitsiidid

Elegant® 2FD Estonya - Estonca - Adama

elegant® 2fd

adama - suspo-emulsioon - 2.4d + florasulaam - herbitsiidid

Leopard® Estonya - Estonca - Adama

leopard®

adama - emulsioonikontsentraat - kvisalofop-p-etüül - herbitsiidid

Mirador® Xtra Estonya - Estonca - Adama

mirador® xtra

adama - suspensioonikontsentraat - asoksüstrobiin + tsüprokonasool - fungitsiidid

Flebogamma DIF (previously Flebogammadif) Avrupa Birliği - Estonca - EMA (European Medicines Agency)

flebogamma dif (previously flebogammadif)

instituto grifols s.a. - inimese normaalne immunoglobuliin - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - suguhormoonid ja immunoglobuliinid, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Hizentra Avrupa Birliği - Estonca - EMA (European Medicines Agency)

hizentra

csl behring gmbh - inimese normaalne immunoglobuliin (scig) - immunoloogilise puudulikkuse sündroomid - suguhormoonid ja immunoglobuliinid, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.

Nobilis IB Primo QX Avrupa Birliği - Estonca - EMA (European Medicines Agency)

nobilis ib primo qx

intervet international b.v. - elus lindude nakkav bronhiit viirus, tüvi d388 - live viral vaccines, domestic fowl - kana - kana aktiivseks immuniseerimiseks, et vähendada infektsioosse bronhiidi qx-tüüpi variantide põhjustatud lindude nakkusliku bronhiidi hingamisteede nähud.

Poulvac IB Primer lüofilisaat okulonasaalsuspensiooni valmistamiseks/joogivees manustamiseks Estonya - Estonca - Ravimiamet

poulvac ib primer lüofilisaat okulonasaalsuspensiooni valmistamiseks/joogivees manustamiseks

zoetis belgium s.a. - lindude nakkava bronhiidi viirusvaktsiin - lüofilisaat okulonasaalsuspensiooni valmistamiseks/joogivees manustamiseks - 1000eid50 1annust 2500annust 10tk; 1000eid50 1annust 5000annust 10tk; 1000eid50 1annust 1000annust 10tk

Sultan® 500 SC Estonya - Estonca - Adama

sultan® 500 sc

adama - suspensioonikontsentraat - metasakloor - herbitsiidid